Glaxo Singled Out in China Probe, Smith Says

Glaxo Singled Out in China Probe, Smith Says Play

July 24 (Bloomberg) -- Andy Smith, chief investment officer at Mann Bioinvest Ltd., talks about the Chinese probe of GlaxoSmithKline Plc over allegations of bribery and corruption. He speaks with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus